Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20039425 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: Placebo;   Drug: Methotrexate

Indicates status has not been verified in more than two years